Validation of an extrinsic compression and early ambulation protocol after diagnostic transfemoral cerebral angiography: a 5-year prospective series.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 08 11 2018
revised: 12 12 2018
accepted: 17 12 2018
pubmed: 25 1 2019
medline: 31 10 2019
entrez: 25 1 2019
Statut: ppublish

Résumé

Access-site complications constitute a substantial portion of the morbidity associated with transfemoral cerebral angiography, yet no standardized protocol exists for femoral closure and practice patterns vary widely. The objective of this single-arm prospective cohort study was to validate the efficacy and safety of a standardized femoral closure strategy for all diagnostic angiography, regardless of antiplatelet regimen. A single-arm, prospective study was designed enrolling consecutive patients undergoing diagnostic transfemoral cerebral angiography by a single neurointerventional surgeon from March 2013 - March 2018. The closure protocol consisted of 20 minutes of manual compression to the site of arterial access and 2 hours of bedrest. The primary outcome was hematoma or oozing after manual compression. Demographic, clinic, and laboratory data were collected and analyzed, and patients were stratified by antiplatelet use. Of 525 angiograms, 263 (50.1%) were on patients taking antiplatelet medication, with 66 (12.6%) on dual antiplatelet regimens. Five patients (0.95% of all patients) met the primary outcome: in all five cases, there was no further oozing or enlarging hematoma after the additional compression period. There were not significant differences in primary outcome in groups stratified by antiplatelet use, and there were no instances of delayed hematoma, pseudoaneurysm, or arteriovenous fistula. In this single-arm cohort study of 525 consecutive transfemoral angiograms with a standardized extrinsic compression protocol, hemostasis was achieved without complication in >99% regardless of antiplatelet strategy. This protocol is effective and safe for diagnostic transfemoral angiography regardless of a patient's antiplatelet use.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Access-site complications constitute a substantial portion of the morbidity associated with transfemoral cerebral angiography, yet no standardized protocol exists for femoral closure and practice patterns vary widely. The objective of this single-arm prospective cohort study was to validate the efficacy and safety of a standardized femoral closure strategy for all diagnostic angiography, regardless of antiplatelet regimen.
METHODS METHODS
A single-arm, prospective study was designed enrolling consecutive patients undergoing diagnostic transfemoral cerebral angiography by a single neurointerventional surgeon from March 2013 - March 2018. The closure protocol consisted of 20 minutes of manual compression to the site of arterial access and 2 hours of bedrest. The primary outcome was hematoma or oozing after manual compression. Demographic, clinic, and laboratory data were collected and analyzed, and patients were stratified by antiplatelet use.
RESULTS RESULTS
Of 525 angiograms, 263 (50.1%) were on patients taking antiplatelet medication, with 66 (12.6%) on dual antiplatelet regimens. Five patients (0.95% of all patients) met the primary outcome: in all five cases, there was no further oozing or enlarging hematoma after the additional compression period. There were not significant differences in primary outcome in groups stratified by antiplatelet use, and there were no instances of delayed hematoma, pseudoaneurysm, or arteriovenous fistula.
CONCLUSION CONCLUSIONS
In this single-arm cohort study of 525 consecutive transfemoral angiograms with a standardized extrinsic compression protocol, hemostasis was achieved without complication in >99% regardless of antiplatelet strategy. This protocol is effective and safe for diagnostic transfemoral angiography regardless of a patient's antiplatelet use.

Identifiants

pubmed: 30674635
pii: neurintsurg-2018-014572
doi: 10.1136/neurintsurg-2018-014572
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-840

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Daniel A Tonetti (DA)

Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Stroke Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Christopher Ferari (C)

West Virginia University School of Medicine, Morgantown, West Virginia, USA.

Jennifer Perez (J)

Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Alp Ozpinar (A)

Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Ashutosh P Jadhav (AP)

Stroke Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Tudor G Jovin (TG)

Stroke Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Bradley A Gross (BA)

Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Stroke Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Brian Thomas Jankowitz (BT)

Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Stroke Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH